Back
SpringWorks Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
SWTX
SpringWorks Therapeutics
Last Price:
$46.10
Seasonality Move:
-1.98%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
SpringWorks Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.18 | Sell |
| 20-day SMA: | 45.07 | Buy |
| 50-day SMA: | 44.77 | Buy |
| 200-day SMA: | 39.82 | Buy |
| 8-day EMA: | 46.05 | Buy |
| 20-day EMA: | 45.12 | Buy |
| 50-day EMA: | 44.61 | Buy |
| 200-day EMA: | 41.64 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 57.85 | Buy |
| Chaikin Money Flow: | -4860653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.78 - 47.3) | Buy |
| Bollinger Bands (100): | (36.63 - 51.11) | Buy |
SpringWorks Therapeutics Technical Analysis
| May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 46.11 while SWTX 8-day simple moving average is 46.18, which is a Sell signal.
-
The stock price of SWTX is 46.11 while SpringWorks Therapeutics 20-day SMA is 45.07, which makes it a Buy.
-
SpringWorks Therapeutics 50-day simple moving average is 44.77 while SWTX share price is 46.11, making it a Buy technically.
-
SWTX stock price is 46.11 and SpringWorks Therapeutics 200-day simple moving average is 39.82, creating a Buy signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
27
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $46.11. The Score for SWTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
3.5B
Price in USD:
46.11
Share Volume:
7.3M
SpringWorks Therapeutics 52-Week Range
52-Week High:
62.00
52-Week Low:
28.21
Sell
27
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 46.11 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 46.11 while SWTX 8-day exponential moving average is 46.05, which is a Buy signal.
-
The stock price of SWTX is 46.11 while SpringWorks Therapeutics 20-day EMA is 45.12, which makes it a Buy.
-
SpringWorks Therapeutics 50-day exponential moving average is 44.61 while SWTX share price is 46.11, making it a Buy technically.
-
SWTX stock price is 46.11 and SpringWorks Therapeutics 200-day simple moving average is 41.64, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $3.01 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is 0.86, suggesting SpringWorks Therapeutics is a Buy
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 57.85, which suggest SpringWorks Therapeutics is overbought
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (39.78 - 47.3), which suggest SpringWorks Therapeutics is a Buy
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (36.63 - 51.11), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.